HPV vaccine re-assessment requested after efficacy data concerns in Germany
This article was originally published in Scrip
Executive Summary
The German Federal Joint Committee, which determines the reimbursements of drugs and services in the German public health system, has requested a scientific re-assessment of the country's HPV vaccination programme, following a statement by scientists flagging concerns over the efficacy data on the cervical cancer vaccines Gardasil and Cervarix.